Stem Cell Therapy for Diabetic Retinopathy Cost in Tijuana, Mexico

Prices in 2026 typically range from $5,000 to $12,000, significantly lower than in the U.S. Final costs depend on the number of injections and specific stem cell types required for treatment.

Tijuana offers proximity to the U.S. border, lower operational costs, and established regenerative medicine protocols, making advanced diabetic retinopathy care accessible and cost-effective.

The process involves harvesting or preparing mesenchymal stem cells, which are then administered via specialized injections to repair damaged retinal tissues and improve vascular health.

Patients often report improved visual acuity and stabilized blood vessel health. Success varies by individual, but many experience a reduction in the progression of vision loss.

When performed in certified facilities following international standards, the procedure is safe. Mexico's COFEPRIS regulates regenerative medicine to ensure patient safety and quality care.

Most patients experience a quick recovery, often returning to normal activities within 24 to 48 hours. Minimal downtime is a key advantage of this minimally invasive regenerative approach.

Clinics primarily use umbilical cord-derived mesenchymal stem cells (UC-MSCs) or adipose-derived cells, known for their potent anti-inflammatory and regenerative properties in eye tissue.

Most treatment plans require a 2 to 3-day stay. This allows for the initial consultation, the procedure itself, and a follow-up observation to ensure optimal healing before traveling home.

Ideal candidates are those with stable blood sugar levels experiencing vision impairment. A thorough medical evaluation is required to determine if regenerative therapy is the right path.

Most U.S. and Canadian insurance providers do not cover elective regenerative treatments abroad. Patients typically pay out-of-pocket, benefiting from Tijuana’s lower procedural pricing.

Stem cell therapy in Tijuana is generally 50% to 70% cheaper than in the U.S., where such advanced treatments may still be restricted or significantly more expensive due to high overheads.

Treatments are regulated by COFEPRIS, Mexico’s health authority, which enforces strict guidelines for cell handling and clinical applications to protect all international medical tourists.